7M16
Triazole-based BET family bromodomain inhibitor bound to BRD4(D1)
Summary for 7M16
Entry DOI | 10.2210/pdb7m16/pdb |
Descriptor | Bromodomain-containing protein 4, 4-{5-[6-(3,5-dimethylanilino)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidine-1-carboximidamide (3 entities in total) |
Functional Keywords | inhibitor, protein binding |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 15503.89 |
Authors | Johnson, J.A.,Pomerantz, W. (deposition date: 2021-03-12, release date: 2021-09-29, Last modification date: 2023-10-18) |
Primary citation | Carlson, A.S.,Cui, H.,Divakaran, A.,Johnson, J.A.,Brunner, R.M.,Pomerantz, W.C.K.,Topczewski, J.J. Systematically Mitigating the p38alpha Activity of Triazole-based BET Inhibitors ACS Med. Chem. Lett., 10:1296-1301, 2019 Cited by DOI: 10.1021/acsmedchemlett.9b00227PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.42 Å) |
Structure validation
Download full validation report